Skip to search boxSkip to navigationSkip to main content

Nephrin is expressed in the pancreatic beta cells

  • T. Palmén
    ,
  • H. Ahola
    ,
  • J. Palgi
    ,
  • P. Aaltonen
    ,
  • P. Luimula
    ,
*Corresponding author for this work
  • University of Helsinki
    ,
  • University of Turku
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Aims/hypothesis. The NPHS1 gene product, nephrin, is a crucial component of the glomerular filtration barrier preventing proteinuria and previously assumed to be kidney-specific. The aim of this study was to describe the expression of nephrin mRNA and protein in human pancreas as well as identify the nephrin-expressing cell types. Methods. RNA dot blot, reverse transcriptase-polymerase chain reaction, sequencing, immunoblotting and dual immunofluorescence were used for the characterisation of nephrin in the pancreas. Results. Except for the kidney, the pancreas was found to be the only tissue expressing nephrin as screened with a human tissue RNA dot blot. The expression was verified with reverse transcriptase-polymerase chain reaction and by sequencing nephrin from a human pancreatic complementary DNA library. Nephrin antibody in immunoblot detected a 165000 Mr protein in the pancreas. Dual immunofluorescence showed that nephrin was specifically localised in the beta cells of the islets of Langerhans. There was no overlap with glucagon, somatostatin, or the ductal cell marker cytokeratin 19. Conclusion/interpretation. These data show that nephrin is a novel molecule of pancreatic beta cells.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 1274-1280 (7 pages)

Journal (Volume, Issue Number)

Diabetologia (Volume 44, Issue 10)

Publication milestones

  • Published - 2001

Publication status

Published - 2001

ISSN

0012-186X

Publication IDs

  • Scopus: 0034775038
  • PubMed: 11692176

Publication metrics

Metrics

Fractional count
1
Fractional count
0.10
Fractional count
9
Fractional count
0.90
Fractional count
1
Fractional count
1
SciVal
FWCI
1.46
SciVal
Author count
10
SciVal
citations
47
SciVal
Paper percentile
85
Scopus
citations

PlumX, opens in new tab

Mentions
3
Citation count
52
Captures
25

Funding Details

Acknowledgements. This study was supported by the Helsinki University Hospital, the Päivikki and Sakari Sohlberg Foundation, the Finnish Foundation of Diabetes Research and the Sigrid Juselius Foundation. T. Otonkoski is the recipient of a Juvenile Diabetes Foundation International Career Development Award. We are also indebted to L. Pirinen, E. Häyri and R. Majuri for their excellent practical assistance. In addition, we thank E. Åström (M. Sci) and J. Ustinov (M. Sci) for their valuable help.